HOM 5307 Exam 1 Set 5 Questions and Answers Solved Correctly Rated A+
T or F: Recent legislation encourages separate lifetime limits for behavioral care. - Answers False
T or F: Extended inpatient treatment for substance abuse is clearly more effective, but too costly. -
Answers False
T or F: Behavioral health care providers are paid under methodologies similar to those applied to
medical/surgical care providers. - Answers True
T or F: Pay for performance (P4P) cannot be applied to behavioral health care providers. - Answers False
What statement is true regarding the trends of traditional, non-specialty drugs (mostly oral and topical
drugs dispensed in community pharmacy) and specialty drugs (biotech, injectables, high-cost orals)? -
Answers Many expensive and popular traditional drugs are losing patent protection, and generics are
driving a declining cost trend. A growing number of the drugs in the pipeline for FDA approval are
injectable products and the specialty drug trend, already at 20%, is expected to increase.
Electronic prescribing offers which of the following potential outcomes? - Answers Improvement in
physician drug formulary prescribing conformance
Reduction in drug interactions and resulting serious adverse effects
Reduction in prescribing and dispensing errors
In January 2006, what large federal prescription drug program was implemented that offered pharmacy
benefits to more than 40 million people at that time and is expected to increase by 30% throughout the
next decade? - Answers Medicare Part D
Two desirable outcomes of tiered prescription member copayments are: - Answers The use of less
expensive generic drugs increases and members save money by paying lower Tier 1 generic copayments
One potential negative consequence of drug formularies with high copayments is: - Answers High
copayments may be a barrier to adherence
What is the common benefit design trend in commercial (employer group sponsored) prescription drug
benefits? - Answers Increasing copayment amounts, especially for Tier 2 preferred brand drugs and Tier
3 non-preferred brand drugs.
Increasing use of percent coinsurance, especially for Tier 3 and Tier 4 specialty tiers when available..
Increasing number of consumer-directed health plan designs with higher front-end deductibles.
What technique is used by many pharmaceutical companies with health plans and PBMs to increase
formulary access and utilization of specific products? - Answers Rebates for preferred formulary position
Health economic data, including a growing number of head-to-head clinical trials
T or F: Recent legislation encourages separate lifetime limits for behavioral care. - Answers False
T or F: Extended inpatient treatment for substance abuse is clearly more effective, but too costly. -
Answers False
T or F: Behavioral health care providers are paid under methodologies similar to those applied to
medical/surgical care providers. - Answers True
T or F: Pay for performance (P4P) cannot be applied to behavioral health care providers. - Answers False
What statement is true regarding the trends of traditional, non-specialty drugs (mostly oral and topical
drugs dispensed in community pharmacy) and specialty drugs (biotech, injectables, high-cost orals)? -
Answers Many expensive and popular traditional drugs are losing patent protection, and generics are
driving a declining cost trend. A growing number of the drugs in the pipeline for FDA approval are
injectable products and the specialty drug trend, already at 20%, is expected to increase.
Electronic prescribing offers which of the following potential outcomes? - Answers Improvement in
physician drug formulary prescribing conformance
Reduction in drug interactions and resulting serious adverse effects
Reduction in prescribing and dispensing errors
In January 2006, what large federal prescription drug program was implemented that offered pharmacy
benefits to more than 40 million people at that time and is expected to increase by 30% throughout the
next decade? - Answers Medicare Part D
Two desirable outcomes of tiered prescription member copayments are: - Answers The use of less
expensive generic drugs increases and members save money by paying lower Tier 1 generic copayments
One potential negative consequence of drug formularies with high copayments is: - Answers High
copayments may be a barrier to adherence
What is the common benefit design trend in commercial (employer group sponsored) prescription drug
benefits? - Answers Increasing copayment amounts, especially for Tier 2 preferred brand drugs and Tier
3 non-preferred brand drugs.
Increasing use of percent coinsurance, especially for Tier 3 and Tier 4 specialty tiers when available..
Increasing number of consumer-directed health plan designs with higher front-end deductibles.
What technique is used by many pharmaceutical companies with health plans and PBMs to increase
formulary access and utilization of specific products? - Answers Rebates for preferred formulary position
Health economic data, including a growing number of head-to-head clinical trials
